Viewing Study NCT06368167


Ignite Creation Date: 2025-12-25 @ 12:43 AM
Ignite Modification Date: 2025-12-25 @ 10:55 PM
Study NCT ID: NCT06368167
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-04-16
First Post: 2024-04-11
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase II Study of SHR2554 in Patients With Relapsed or Refractory Follicular Lymphoma
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module